Abbott Laboratories: 10-K Risk Factor Changes

2024 vs 2023  ·  SEC EDGAR  ·  2026-10-16
Other years: 2026 vs 2025 · 2025 vs 2024
⚠ AI Risk Brief Interpretation layer — deterministic data below

Abbott added tax risk disclosure and substantially expanded public health, supply chain, cybersecurity, and regulatory compliance concerns.

Direction ↑ More concerning
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

1
New Risks
0
Removed
5
Modified
15
Unchanged
🟢 New in Current Filing Disclosure change7/10

Adverse changes in tax laws, regulations and interpretations, both in the U.S. and internationally, could have a material adverse effect on Abbott’s effective tax rate, financial condition and results of operations.

🟡 Modified Abbott is subject to risks related to public health crises, such as widespread outbreaks of infectious diseases like the COVID-19 pandemic, which had a material effect on Abbott’s business, financial condition and results of operations. 🔒
🟡 Modified Disruptions to Abbott’s global supply chain, which is large and complex, could negatively affect Abbott’s results of operations. 🔒
🟡 Modified Abbott depends on sophisticated information systems and maintains protected personal data, and a significant cybersecurity incident or other disruption affecting these information systems or protected data could have a material adverse effect on Abbott’s business, financial condition and results of operations. 🔒

And 2 more changes in the full comparison.

5 changes in this historical filing

The complete historical comparison (2024 vs 2023) is available on the Pro plan.

Get Pro access Already a Pro subscriber? View full diff →